Meet the expert...
Rebecca McQualter
Chief Operating Officer/Acting CEO at Chimeric Therapeutics Ltd

Dr. Rebecca McQualter is the Chief Operating Officer and Acting CEO of Chimeric Therapeutics Ltd, based in Melbourne, Australia.
With over two decades of experience in the biotech industry, Dr. McQualter has been at the forefront of pioneering cell therapy innovations, leading the development of first-in-class CAR-T therapies targeting various cancers, including gastric, pancreatic, and glioblastoma.
Known for her strategic leadership and commitment to advancing cutting-edge technology, she plays a critical role in shaping the future of biotech and improving patient outcomes globally.